Georgia’s healthcare landscape is evolving rapidly, with oncology emerging as one of the most critical and expanding segments. Cancer ranks among the leading causes of morbidity and mortality in the country, driving steady demand for effective treatments. Collaboration with leading cancer drug development companies further strengthens access to both innovative and generic therapies. In this